BR0318652A - composição de ervas para o tratamento de disfunções gastrointestinais - Google Patents

composição de ervas para o tratamento de disfunções gastrointestinais

Info

Publication number
BR0318652A
BR0318652A BRPI0318652-0A BR0318652A BR0318652A BR 0318652 A BR0318652 A BR 0318652A BR 0318652 A BR0318652 A BR 0318652A BR 0318652 A BR0318652 A BR 0318652A
Authority
BR
Brazil
Prior art keywords
treatment
herbs
herbal composition
antidiarrheal
gastrointestinal dysfunction
Prior art date
Application number
BRPI0318652-0A
Other languages
English (en)
Inventor
Pushpangadan Palpu
Chandana Rao Venkateswara
Ajay Rawat Singh Kumar
Mehotra Shanta
Sanjeev Ojha Kumar
Original Assignee
Council Of Scientif & Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Of Scientif & Ind Res filed Critical Council Of Scientif & Ind Res
Publication of BR0318652A publication Critical patent/BR0318652A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

"COMPOSIçãO DE ERVAS PARA O TRATAMENTO DE DISFUNçõES GASTROINTESTINAIS". A invenção fornece nova forma de dosagem de ervas antidiarreica para o tratamento das desordens funcionais gastrointestinais tais como a sindrome do intestino irritável e diarréia. A formulação de ervas antidiarreica compreende a decocção de Cissampelos pareira, Mangifera indica, Cinnamomum sp. e Buchanania lanzan com os aditivos convencionais para formar as dosagens de forma oral, que inclui xarope, tabletes, cápsulas e pós prontos para suspensão.
BRPI0318652-0A 2003-12-29 2003-12-29 composição de ervas para o tratamento de disfunções gastrointestinais BR0318652A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000406 WO2005063271A1 (en) 2003-12-29 2003-12-29 Herbal composition for gastrointestinal disorders

Publications (1)

Publication Number Publication Date
BR0318652A true BR0318652A (pt) 2006-11-28

Family

ID=34717538

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0318652-0A BR0318652A (pt) 2003-12-29 2003-12-29 composição de ervas para o tratamento de disfunções gastrointestinais

Country Status (9)

Country Link
US (1) US7172772B2 (pt)
EP (1) EP1708789B1 (pt)
JP (1) JP4673220B2 (pt)
CN (1) CN1909915B (pt)
AU (1) AU2003290406A1 (pt)
BR (1) BR0318652A (pt)
DE (1) DE60322983D1 (pt)
GB (1) GB2426705B (pt)
WO (1) WO2005063271A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070190171A1 (en) 2005-12-02 2007-08-16 Yamka Ryan M Methods for Altering Stool Quality and/or Stool Frequency
WO2011083398A2 (en) * 2010-01-05 2011-07-14 Himalaya Global Holdings Limited Herbal composition for diarrhoea
CN106074278B (zh) 2010-09-09 2020-11-27 玫琳凯有限公司 包含植物提取物的局部护肤制剂
KR101521341B1 (ko) * 2013-02-27 2015-05-18 씨제이헬스케어 주식회사 북두근, 북두근 추출물, 북두근 오니 또는 북두근 맥아 효소액 추출물을 유효성분으로 함유하는 식욕부진 예방 또는 치료용 조성물
CN104147290A (zh) * 2014-08-17 2014-11-19 郭少敏 一种治疗细菌性痢疾的中药制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2115707A1 (en) 1993-02-16 1994-08-17 Takashi Tokuyama Antiulcer agent
CA2182917C (en) 1996-03-26 2001-05-08 Alvin B. Segelman Composition and method for treating and preventing helicobactor pylori-associated stomach gastritis, ulcers and cancer
DE60107393T2 (de) 2000-03-01 2005-12-01 Euro-Celtique S.A. Verwendung von tramadol zur herstellung eines arzneimittels zur behandlung von funktionelle gastrointestinale krankenheiten

Also Published As

Publication number Publication date
DE60322983D1 (de) 2008-09-25
GB2426705B (en) 2008-05-07
CN1909915B (zh) 2010-05-26
GB0613010D0 (en) 2006-08-23
JP2009502731A (ja) 2009-01-29
JP4673220B2 (ja) 2011-04-20
EP1708789B1 (en) 2008-08-13
AU2003290406A1 (en) 2005-07-21
US20050142227A1 (en) 2005-06-30
GB2426705A (en) 2006-12-06
EP1708789A1 (en) 2006-10-11
US7172772B2 (en) 2007-02-06
WO2005063271A1 (en) 2005-07-14
CN1909915A (zh) 2007-02-07

Similar Documents

Publication Publication Date Title
HK1060694A1 (en) Herbal compositions useful as chemopreventive and therapeutic agents.
CL2004000827A1 (es) Compuestos derivados de 1,2-diazoles o 1,3-diazoles condensados con un heterociclo, composicion farmaceutica; y uso para tratar enfermedades moduladas por antagonistas de receptores canabinoides, tales como obesidad y sobrepeso.
WO2005120158A3 (en) Herbal compositions for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same
NO20015405D0 (no) Ny sammensetning
BRPI0507747A (pt) medicamento com base em planta para o tratamento da hepatite c
BR0109936A (pt) Compostos contendo piperidina benzoamida e compostos relacionados
WO2000072837A3 (en) Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives
WO2005010032A3 (en) Replikin peptides and uses thereof
TR199900318T2 (xx) IL-8 resept�r antagonistleri.
SV2007002226A (es) Ligandos de difenil eter terapeuticos ref. pc26176a
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
NO20060832L (no) Behandling av aspirin resistens med radix salvie miltiorrhiaze, dens ekstrakt og sammensetning
TNSN06024A1 (en) Stable modifications of tegaserod hydrogen maleate
EE200400005A (et) Tablett, mis sisaldab vähemalt kahte eristatavat segmenti ning selle kasutamine
BR0318652A (pt) composição de ervas para o tratamento de disfunções gastrointestinais
DE60041655D1 (de) Auslösender rezeptor der an der natürlichen cytotoxizität der menschlichen natürlichen killerzellen (natural killer cells) beteiligt ist und antikörper die diesen rezeptor identifizieren
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
MXPA02012894A (es) Catecoles nitrados substituidos, su uso en el tratamiento de algunos trastornos del sistema nervioso central y periferico y composiciones farmaceuticas que los contienen.
ITRM950273A0 (it) Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni farmaceutiche.
TR200103354T2 (tr) IL-8 Reseptör antagonistleri
Khayyat Nori et al. Effect of hydroalcoholic extract of Avena sativa L. on morphine withdrawal signs in male mice
EA200970777A1 (ru) Травяные композиции, содержащие растительный материал полыни artemisia herba-alba( asso) asteraceae и/или его экстракт
KR960033299A (ko) 두충엽을 주원료로 함유한 건강식품 조성물
TW200607520A (en) Use of Salvia, its extracts and composition thereof for treating aspirin resistance

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 35/78 , A61P 1/12

Ipc: A61K 36/22 (2006.01), A61K 36/59 (2006.01), A61K 3

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements